Programme Introduction
About this programme
💊 Pharmacy Practice
✅ Regulatory & Clinical
📋 Case-Based Learning
Biopharmaceuticals and biosimilars represent one of the fastest-growing categories of modern medicine, and their molecular complexity means they are regulated and used differently from conventional small-molecule drugs.
Understanding how biosimilars are developed, evaluated, and approved — including how they differ from generic small-molecule drugs — is essential as more of these products enter clinical use worldwide.
TerraLeap’s Biopharmaceuticals & Biosimilars course is designed for pharmacists and life-sciences learners, covering molecular basics, the regulatory pathway, and clinical use considerations.
The course covers the molecular structure and manufacturing basis of biopharmaceuticals, the regulatory framework for biosimilar approval, and practical considerations for clinical use and substitution.
Clinical and regulatory expertise — built for real pharmacy practice.
Programme Scope
What this programme covers
This course covers molecular basics, regulation, and clinical use for biopharmaceuticals and biosimilars.
🧬
Molecular basics
Structure and manufacturing basis of biopharmaceutical products.
📋
Regulatory pathway
How biosimilars are evaluated and approved by regulators.
🔬
Biosimilar vs. generic distinction
Why biosimilar evaluation differs from conventional generic drug approval.
💊
Clinical use considerations
Practical considerations for prescribing and substitution.
⚠️
Immunogenicity awareness
Understanding immunogenicity considerations specific to biologics.
📊
Pharmacovigilance
Post-marketing safety monitoring specific to biopharmaceuticals.
🌍
Global regulatory variation
How biosimilar regulation varies across major regulatory regions.
Learning Objectives
What you will achieve
After completing this course, learners will be able to describe biopharmaceutical and biosimilar molecular basics, regulation, and clinical use considerations.
Each objective addresses a core biopharmaceuticals and biosimilars competency.
01
Describe the molecular structure and manufacturing basis of biopharmaceutical products
02
Explain how biosimilars are evaluated and approved by regulators
03
Distinguish biosimilar evaluation from conventional generic drug approval
04
Apply practical considerations for prescribing and substitution of biosimilars
05
Understand immunogenicity considerations specific to biologic therapies
06
Describe post-marketing safety monitoring practices for biopharmaceuticals
07
Compare biosimilar regulation across major global regulatory regions
Target Audience
Who can enroll
This course is designed for pharmacists and life-sciences learners building knowledge of biopharmaceuticals and biosimilars.
Whether your interest is clinical practice or life-sciences research, this course builds practical understanding of this fast-growing therapeutic category.
💊
Pharmacists dispensing or advising on biopharmaceutical products
🔬
Life-sciences learners studying biopharmaceutical development
🏥
Clinical staff involved in biosimilar substitution decisions
📚
Students building foundational biopharmaceutical knowledge
📋
Regulatory and pharmacovigilance professionals
Programme Certification
Your certificate
Upon successful completion of this programme, you will receive a digital certificate recognising your achievement and the competencies you have acquired throughout the course.
Certificates for TerraLeap programmes are issued and signed by authorised TerraLeap representatives. For programmes delivered in collaboration with universities, institutions, or industry organisations, certificates are jointly issued and co-signed by authorised representatives of both TerraLeap and the respective partner.
Each certificate carries a unique Certificate ID and QR code to enable instant authenticity verification — making it easy to share with employers, licensing bodies, or professional networks as evidence of your learning.
Note on scope. TerraLeap certificates confirm successful completion of the respective programme and recognise your professional development and continuing education. They do not constitute a professional licence or regulatory authorisation unless explicitly stated in the programme description.
TERRALEAP
Certificate ID
TL-2026-AB7K3X9P
Official
Seal
Certificate of Completion
Successfully Completed
Awarded in recognition of academic achievement
This is to certify that
XXXXX
has successfully completed the prescribed course of study, demonstrating commitment, diligence, and proficiency in
Basics of Biopharmaceuticals and Biosimilars
and is hereby awarded this certificate by TerraLeap, recognising the candidate's mastery of the syllabus and successful evaluation.